LEADER 00000cam  2200637Ii 4500 
001    ocn957125869 
003    OCoLC 
005    20221005213019.0 
006    m     o  d         
007    cr |n|---||||| 
008    160827s2015    dk      ob    001 0 eng d 
019    1055371681|a1066521732|a1081184537 
020    9788793237100 
020    8793237103 
020    879323709X 
020    9788793237094 
020    |z9788793237094 
035    (OCoLC)957125869|z(OCoLC)1055371681|z(OCoLC)1066521732
       |z(OCoLC)1081184537 
040    EBLCP|beng|epn|cEBLCP|dOCLCO|dOCLCQ|dCCO|dOCLCO|dOCLCF
       |dMERUC|dLOA|dCOCUF|dK6U|dSTF|dPIFAG|dFVL|dOCLCQ|dZCU|dU3W
       |dWRM|dICG|dVT2|dOCLCQ|dWYU|dTKN|dDKC|dAU@|dOCLCQ|dOCL
       |dOCLCQ|dCUI|dOCLCA|dOCLCO 
049    STJJ 
050  4 R857.T55|b.I566 2015eb 
082 04 616.02774 
100 1  Prasad, Mayuri. 
245 10 Innovative Strategies in Tissue Engineering. 
264  1 Aalborg :|bRiver Publishers,|c2015. 
300    1 online resource (211 pages). 
336    text|btxt|2rdacontent 
337    computer|bc|2rdamedia 
338    online resource|bcr|2rdacarrier 
490 1  River Publishers Series in Research and Business 
       Chronicles: Biotechnology and Medicine 
500    7. Novel Design of Manufacturing Bioreactorand Facility of
       Cell-Based Health CareProducts for Regenerative Medicine. 
504    Includes bibliographical references at the end of each 
       chapters and index. 
505 0  Cover; Half Title; Title; Copyright; Contents; Preface; 
       List of Figures; List of Abbreviations; 1. Bioactive 
       Nanocomposites withApplications in Biomedicine; Abstract; 
       1.1 Introduction; 1.2 Factors that Influence the Quality 
       of a Biomaterial; 1.3 Layered Silicate Nanocomposites for 
       Biomaterials; 1.3.1 Layered Silicate Properties; 1.3.2 
       Layered Silicate Purification; 1.3.3 Layered Silicate in 
       Drug Release Systems; 1.3.4 Biopolymers Properties; 1.4 
       Routes for Obtaining Bio-Nanocomposites; 1.5 Biomaterials 
       Development; 1.6 Conclusions; References. 
505 8  2. Cerium Dioxide Nanoparticles ProtectCardiac Progenitor 
       Cells against theOxidative StressAbstract; 2.1 Interaction
       of Cerium Oxide Nanoparticleswith Biological Systems; 2.2 
       Cerium Oxide Nanoparticles Shield Cardiac PrecursorCells 
       against the Oxidative Stress; References; 3. Animals 
       Models and In Vitro Alternativesin Regenerative Medicine: 
       Focus onBiomaterials Development; 3.1 Introduction; 3.1.1 
       Animals in Medical Research; 3.1.2 Ethical Considerations 
       of Animal Use; 3.2 Designing Animal Experiments; 3.2.1 
       Randomization and Blinding; 3.2.2 Control Groups; 3.2.3 
       Statistical Analysis. 
505 8  3.2.4 Design Stages3.3 Limitations of Animal Models; 3.3.1
       Animal Species; 3.3.2 Health and Age Status; 3.3.3 
       Reproducibility; 3.4 Examples of Animal Models for Cardiac
       and CornealRegenerative Medicine Testing; 3.4.1 Myocardial
       Infarct and Other Ischemic Models; 3.4.1.1 Myocardial 
       coronary artery ligation; 3.4.1.3 Hind-limb ischemia; 
       3.4.1.2 Cryoinjury; 3.4.2 Corneal Transplantation Models; 
       3.4.2.1 Animal species; 3.4.2.2 Lamellar and penetrating 
       keratoplasty; 3.4.2.3 Infectious models; 3.5 In Vitro 
       Systems as Alternatives to Animal Testing. 
505 8  3.5.1 In Vitro Corneal Equivalents for Screening 
       Biomaterialsas Potential Implants3.5.2 In Vitro 
       Angiogenesis Models; 3.6 Conclusion; References; 4. 
       Differentiation Plasticity of GermlineCell-Derived 
       Pluripotent Stem Cells andTheir Potential Application in 
       RegenerativeMedic; Abstract; 4.1 Introduction; 4.2 
       Hepatocytes Derived from GPSCs; 4.3 Cardiac Cells Derived 
       from GPSCs; 4.4 Neuronal Cells Derived from GPSCs; 4.5 
       Hematopoietic Cells from GPSCs; 4.6 Vascular Cells Derived
       from GPSCs; References; 5. Mechanical Stimulation in 
       TissueEngineering; 5.1 Background and Introduction. 
505 8  5.1.1 Mechanical Theories of Material Damage5.1.2 Damage 
       of Living Tissue; 5.2 Mechanical Loading in Two 
       Dimensions; 5.2.1 Hertz-inspired Tissue Deformation; 5.2.2
       Preliminary Results of Cell Straining; 5.3 Conclusions and
       Outlook; References; 6. Immune Properties of Mesenchymal 
       StemCells in the Translation of Neural Disorders; 
       Abstract; 6.1 Introduction; 6.2 MSC Immunology; 6.3 MSCs 
       and Cancer; 6.3.1 Role in Tumor Growth; 6.3.2 MSCs in 
       Tumor Suppression; 6.3.3 MSC and Brain Cancer; 6.4 
       Regenarative Potential; 6.5 Safety; 6.6 Conclusion; 
       Refrences. 
588 0  Print version record. 
590    Taylor & Francis|bTaylor & Francis eBooks: Open Access 
650  0 Tissue engineering|vCongresses. 
650  0 Nanocomposites (Materials)|vCongresses. 
650  0 Biomedical materials|vCongresses. 
650  0 Stem cells|vCongresses. 
650  7 Biomedical materials.|2fast|0(OCoLC)fst00832586 
650  7 Nanocomposites (Materials)|2fast|0(OCoLC)fst01748679 
650  7 Stem cells.|2fast|0(OCoLC)fst01132975 
650  7 Tissue engineering.|2fast|0(OCoLC)fst01151484 
655  7 Conference papers and proceedings.|2fast
       |0(OCoLC)fst01423772 
700 1  Di Nardo, Paolo. 
776 08 |iPrint version:|aPrasad, Mayuri.|tInnovative Strategies 
       in Tissue Engineering.|dAalborg : River Publishers, ©2015
       |z9788793237094 
830  0 River Publishers series in research and business 
       chronicles: biotechnology and medicine. 
914    ocn957125869 
947    MARCIVE Processed 2022/11/04 
994    92|bSTJ